Floatz logo

Therapeutic Asset Ratings

9,928 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
awt020
Cancer
Shanghai Junshi Bioscience Co., Ltd.P1CC (43)
Axatilimab
Follicular Lymphoma
Northside Hospital, Inc.P1CC (43)
Axatilimab
High Grade B-Cell Lymphoma
Northside Hospital, Inc.P1CC (43)
Axatilimab
Primary Mediastinal Large B-Cell Lymphoma
Northside Hospital, Inc.P1CC (43)
Axicabtagene Ciloleucel
HIV Infectious Disease
AIDS Malignancy ConsortiumP1CC (43)
Axicabtagene Ciloleucel
Primary Central Nervous System Lymphoma
Dana-Farber Cancer InstituteP1CC (43)
Azacitidine
Acute Undifferentiated Leukemia
Therapeutic Advances in Childhood Leukemia ConsortiumP1CC (43)
Azacitidine
Systemic Mastocytosis
Blueprint Medicines CorporationP1CC (43)
Azacitidine
Astrocytoma, IDH-Mutant, Grade 4
Andrew P. GrovesP1CC (43)
Azacitidine
CD4+/CD56+ Hematodermic Neoplasm
Therapeutic Advances in Childhood Leukemia ConsortiumP1CC (43)
Azacitidine
Gliosarcoma
Andrew P. GrovesP1CC (43)
Azacitidine
Acute Myeloid Leukemia, MLL Gene Rearrangement
Kura Oncology, Inc.P1CC (43)
Azacitidine
Monocytic Leukemia
University of Colorado, DenverP1CC (43)
Azacitidine
Nasopharyngeal Squamous Cell Carcinoma
National Cancer Institute (NCI)P1CC (43)
Azacitidine
Undifferentiated Carcinoma Of Nasopharynx
National Cancer Institute (NCI)P1CC (43)
azd0120
Idiopathic Inflammatory Myopathy
AstraZenecaP1CC (43)
azd0120
Rheumatoid Arthritis
AstraZenecaP1CC (43)
azd0120
Systemic Sclerosis
AstraZenecaP1CC (43)
azd1390
Brain Cancer
AstraZenecaP1CC (43)
azd1390
Childhood Astrocytic Tumor
Children's Oncology GroupP1CC (43)
azd1390
Metastatic Neoplasm
Memorial Sloan Kettering Cancer CenterP1CC (43)
azd5305
High Grade Malignant Neoplasm
AstraZenecaP1CC (43)
azd5305
Metastatic Neoplasm
AstraZenecaP1CC (43)
azd5335
Primary Peritoneal Carcinoma
AstraZenecaP1CC (43)
azd6234
Liver Disorder
AstraZenecaP1CC (43)
Showing 1151 to 1175 of 9,928 assets
PreviousPage 47 of 398Next